ABSOLUTE ANTIBODY LTD. Antibodies & Hybridomas — page 87 of 301
Antibodies & Hybridomas
Page 87 of 301
| Specificity | Clone | Host Species | Reactive Species | Format | Size | |
|---|---|---|---|---|---|---|
| Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Recombinant Human | SARS-CoV-2 | Fab fragment-His-tagged | 200 µg | More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Recombinant Mouse | SARS-CoV-2 | Fab fragment-His-tagged | 200 µg | More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Recombinant Human | SARS-CoV-2 | Fab fragment-His-tagged | 200 µg | More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Recombinant Ferret | SARS-CoV-2 | purified | 50 µg | More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Recombinant Ferret | SARS-CoV-2 | purified | 50 µg | More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Recombinant Human | SARS-CoV-2 | purified | 50 µg | More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Recombinant Human | SARS-CoV-2 | purified | 50 µg | More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Recombinant Human | SARS-CoV-2 | purified | 50 µg | More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Recombinant Human | SARS-CoV-2 | purified | 50 µg | More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Recombinant Rabbit | SARS-CoV-2 | purified | 200 µg | More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Recombinant Rabbit | SARS-CoV-2 | purified | 200 µg | More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Recombinant Human | SARS-CoV-2 | purified | 200 µg | More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Recombinant Human | SARS-CoV-2 | purified | 200 µg | More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Recombinant Ferret | SARS-CoV-2 | purified | 200 µg | More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Recombinant Human | SARS-CoV-2 | purified | 200 µg | More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Recombinant Human | SARS-CoV-2 | purified | 200 µg | More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Recombinant Ferret | SARS-CoV-2 | purified | 200 µg | More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Recombinant Cat | SARS-CoV-2 | purified | 200 µg | More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Recombinant Cat | SARS-CoV-2 | purified | 200 µg | More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Recombinant Human | SARS-CoV-2 | purified | 200 µg | More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Recombinant Human | SARS-CoV-2 | purified | 200 µg | More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Recombinant Mouse | SARS-CoV-2 | purified | 200 µg | More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Recombinant Mouse | SARS-CoV-2 | purified | 200 µg | More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Recombinant Mouse | SARS-CoV-2 | purified | 200 µg | More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Recombinant Mouse | SARS-CoV-2 | purified | 200 µg | More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Recombinant Human | SARS-CoV-2 | purified | 200 µg | More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Recombinant Human | SARS-CoV-2 | purified | 200 µg | More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Recombinant Human | SARS-CoV-2 | purified | 50 µg | More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Recombinant Mouse | SARS-CoV-2 | purified | 50 µg | More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Recombinant Cat | SARS-CoV-2 | purified | 50 µg | More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Recombinant Ferret | SARS-CoV-2 | purified | 50 µg | More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Recombinant Human | SARS-CoV-2 | purified | 50 µg | More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Recombinant Mouse | SARS-CoV-2 | purified | 50 µg | More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Recombinant Cat | SARS-CoV-2 | purified | 50 µg | More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Recombinant Ferret | SARS-CoV-2 | purified | 50 µg | More Info |
| COVID-19 & SARS-CoV S glycoprotein | CR3022 | Recombinant Mouse | SARS-CoV-2 | F(ab)2 fragment-His-tagged | 100 µg | More Info |
| COVID-19 & SARS-CoV S glycoprotein | CR3022 | Recombinant Human | SARS-CoV-2 | F(ab)2 fragment-His-tagged | 100 µg | More Info |
| COVID-19 & SARS-CoV S glycoprotein | CR3022 | Recombinant Mouse | SARS-CoV-2 | Fab fragment-His-tagged | 100 µg | More Info |
| COVID-19 & SARS-CoV S glycoprotein | CR3022 | Recombinant Human | SARS-CoV-2 | Fab fragment-His-tagged | 100 µg | More Info |
| COVID-19 & SARS-CoV S glycoprotein | CR3022 | Recombinant Ferret | SARS-CoV-2 | purified | 50 µg | More Info |
| COVID-19 & SARS-CoV S glycoprotein | CR3022 | Recombinant Human | SARS-CoV-2 | purified | 50 µg | More Info |
| COVID-19 & SARS-CoV S glycoprotein | CR3022 | Recombinant Human | SARS-CoV-2 | purified | 50 µg | More Info |
| COVID-19 & SARS-CoV S glycoprotein | CR3022 | Recombinant Rabbit | SARS-CoV-2 | purified | 200 µg | More Info |
| COVID-19 & SARS-CoV S glycoprotein | CR3022 | Recombinant Human | SARS-CoV-2 | purified | 200 µg | More Info |
| COVID-19 & SARS-CoV S glycoprotein | CR3022 | Recombinant Human | SARS-CoV-2 | purified | 200 µg | More Info |
| COVID-19 & SARS-CoV S glycoprotein | CR3022 | Recombinant Ferret | SARS-CoV-2 | purified | 200 µg | More Info |
| COVID-19 & SARS-CoV S glycoprotein | CR3022 | Recombinant Cat | SARS-CoV-2 | purified | 200 µg | More Info |
| COVID-19 & SARS-CoV S glycoprotein | CR3022 | Recombinant Human | SARS-CoV-2 | purified | 200 µg | More Info |
| COVID-19 & SARS-CoV S glycoprotein | CR3022 | Recombinant Mouse | SARS-CoV-2 | purified | 200 µg | More Info |
| COVID-19 & SARS-CoV S glycoprotein | CR3022 | Recombinant Mouse | SARS-CoV-2 | purified | 200 µg | More Info |
ABSOLUTE ANTIBODY LTD.
ABSOLUTE ANTIBODY LTD.
An Absolute Biotech Company
Wilton Centre
Redcar, Cleveland TS10 4RF U.K.
P: +44 (0)1642 688810
F: +44 (0)1642 688815
info@absoluteantibody.com
Technical enquiries: support@absoluteantibody.com
https://absoluteantibody.com
Return to Profile